NCT03775837 Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults
| NCT ID | NCT03775837 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pusan National University Yangsan Hospital |
| Condition | Liver Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2018-12-01 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2018-12-01 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.
Eligibility Criteria
Inclusion Criteria: * ALT ranging from upper limit of reference to three times of upper limit Exclusion Criteria: * Abnormal liver or renal function (i.e., serum aminotransferase activity \> 3 times of upper limit of reference range and serum creatinine concentrations \> 1.2 mg/dL) * Diabetes (diagnosed clinically or fasting glucose level \> 126 mg/dL) * History of viral hepatitis or cancer * Uncontrolled hypertension * History of serious cardiac disease such as angina or myocardial infarction * History of gastrectomy * History of medication for psychiatric disease * Administration of oriental medicine including herbs within the past 4 weeks
Contact & Investigator
Sang Yeoup Lee
PRINCIPAL INVESTIGATOR
Pusan National University Yangsan Hospital
Frequently Asked Questions
Who can join the NCT03775837 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 75 Years, studying Liver Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03775837 currently recruiting?
Yes, NCT03775837 is actively recruiting participants. Contact the research team at saylee@pnu.edu for enrollment information.
Where is the NCT03775837 trial being conducted?
This trial is being conducted at Yangsan, South Korea.
Who is sponsoring the NCT03775837 clinical trial?
NCT03775837 is sponsored by Pusan National University Yangsan Hospital. The principal investigator is Sang Yeoup Lee at Pusan National University Yangsan Hospital. The trial plans to enroll 60 participants.